Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a multinational retrospective analysis | Synapse
March 3, 2026Open Access
Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a multinational retrospective analysis
Key Points
Emergency department attendances were significantly reduced following nirsevimab immunisation, suggesting its effectiveness.
Maternal vaccination against RSV showed a notable decrease in subsequent respiratory disease admissions, highlighting its protective benefits.
Retrospective analysis across multiple countries provides insights into the real-world impact of these interventions on healthcare usage.
Findings emphasize the need for continued evaluation of vaccination strategies to mitigate RSV-related health issues.